• Nenhum resultado encontrado

Inflammation, senescence and cancer: interweaving microRNA, inflammatory cytokines and p53 networks

N/A
N/A
Protected

Academic year: 2017

Share "Inflammation, senescence and cancer: interweaving microRNA, inflammatory cytokines and p53 networks"

Copied!
29
0
0

Texto

(1)

Volume 4 Supplement 2 September 2010

BMC

Proceedings

Abstracts of the 16th International

Charles Heidelberger Symposium on

Cancer Research

(2)

Volume 4 Supplement 2 September 2010

BMC

Proceedings

Abstracts of the 16th International Charles Heidelberger

Symposium on Cancer Research

Coimbra, Portugal

26-28 September 2010

Committees

The Organization of the 16th International Charles Heidelberger Symposium on Cancer Research acknowledges the support of: • FCTUC (Faculdade de Ciências e Tecnologia da Universidade de Coimbra)

• CIUC (Centro de Informática da Universidade de Coimbra)

• DIIC-UC (Divisão de Identidade, Imagem e Comunicação da Universidade de Coimbra) • Turismo de Coimbra

• Turismo Centro de Portugal • Bentham Science Publishers

International Advisory Committee

Eli Huberman (USA) Johan Lillehaug (Norway) Joseph Landolph (USA) Karl Heinrich Link (Germany) Robert Langenbach (USA) Toshio Kuroki (Japan)

Symposium Executive Committee

Eli Huberman (USA) Johan Lillehaug (Norway) Joseph Landolph (USA) Karl Heinrich Link (Germany)

Secretariat

Ana Paula Parreira

Symposium Chairs

Carlos Freire de Oliveira (Portugal) Joseph Landolph (USA)

Eli Huberman (USA) Maria Carmen Alpoim (Portugal)

Local Organizing Committee

Ana Castro Jardim (FMUC) Joana Felício Cerveira (FCTUC)

Ana Daniela Sampaio (FCTUC) Leonardo Manuel Ferreira (FCTUC)

Ana Margarida Urbano (FCTUC) Luís Miguel Pires (FMUC)

António Jorge Guiomar (FCTUC) Maria Carmen Alpoim (FCTUC)

Armando Cristovão (FCTUC) Maria Filomena Botelho (FMUC)

Carlos Freire de Oliveira (FMUC) Marta Pinto Coelho (FMUC) Isabel Maria Abrantes (FCTUC) Paula Vasconcelos Morais (FCTUC) Isabel Marques Carreira (FMUC)

Local Programme Committee

Ana Margarida Urbano (FCTUC) Maria Carmen Alpoim (FCTUC)

(3)

BMC Proccedings is published by: BioMed Central Ltd

Floor 6, 236 Gray’s Inn Road London WC1X 8HB, UK T: +44 (0) 20 3192 20000 F: +44 (0) 20 3192 2010 E info@biomedcentral.com

BMC Proceedings is a peer-review open access online journal publishing proceedings from conferences, including both peer-reviewed full articles and collections of meeting abstracts. Content is not restricted to any particular discipline within biomedicine and all proceedings are published without barriers to access.

Editorial control of BMC Proceedings is in the hands of the journal’s Editor-in-Chief. All enquiries about content or submissions should be sent by email to:

supplements@biomedcentral.com

The journal can be found at

http://www.biomedcentral.com/ (ISSN 1753-6561). Access to BMC Proceedings is free

and available to all.

All articles published by BioMed Central in

BMC Proceedings are open access, which means they are universally and freely accessible via the Internet and deposited in at least one widely and internationally recognized open access repository (such as PubMed Central). Open access also means that the authors or copyright owners grant any third party the right to use, reproduce and disseminate the research article. BioMed Central is committed to maintaining open access for all research articles that it publishes, both retrospectively and

prospectively, in all eventualities, including any future changes in ownership. For more information please refer to the BioMed Central Open Access Charter and permanency of articles webpages accessible from http://www. biomedcentral.com/info/about.

Indexing/abstracting

BMC Proceedings is indexed and/or abstracted by:

• PubMed • PubMed Central

Supplements

Supplements are accepted subject to the approval of the Editor-in-chief. For further information please contact the Editorial Office or email supplements@biomedcentral.com

Advertising

For information about advertising in

BMC Proceedings, including the rate card and specifications, contact the Advertising Department at the above address. Alternatively send an email to: advertising@biomedcentral.com

Reprints

BioMed Central can provide high quality reprints and offers a rapid delivery service. For further information and prices, contact the above address, or send an email to:

reprints@biomedcentral.com

Disclaimer

Whilst every effort is made by the publishers, editor and editorial board to see that no inaccurate or misleading data, opinion, or statement appear in this publication, they wish to make it clear that the data and opinions appearing in the articles and advertisements herein are the responsibility of the contributor or advertiser concerned. Accordingly, the publishers, the editor and editorial board, and their respective employees, officers, and agents accept no liability whatsoever for the consequences of any such inaccurate or misleading data, opinion or statement.

Printer

Latimer Trend & Company Ltd Plymouth, UK

Dan Benhamou (France) Sally Blower (USA) Itzhak Brook (USA) Max Bulsara (Australia) Roger Bumgarner (USA) Rita Casadio (Italy) Kevin Coombes (USA) Julia Critchley (UK) Lalit Dandona (India) Chris Del Mar (Australia)

Alexander Dobrovic (Australia) Edzard Ernst (UK)

Toshiaki A Furukawa (Japan) Debashis Ghosh (USA) S Blair Hedges (USA) Stephen T Holgate (UK) Laurence Hurst (UK) Omar Khan (USA) Mark Lemmon (USA) Judith Lumley (Australia)

Mark Miller (USA) Herve Philippe (Canada) Michael Posner (USA) Antoni Rafalski (USA)

Shoba Ranganathan (Australia) Darryl Shibata (Italy)

Leana Uys (South Africa) Alfried Vogler (UK) Scott Weiss (USA)

Editor-in-Chief

Melissa Norton, MD (UK)

Editorial Board

(4)

Volume 4 Supplement 2 September 2010

BMC

Proceedings

Contents

Opening Lecture

O1 Inflammation, senescence and cancer: interweaving microRNA, inflammatory cytokines and p53 networks

Curtis C. Harris

Session 1 - Cancer Etiology and Epidemiology

O2 Gene-environment in the induction of cancer

Herman Autrup

O3 Gene variants and lung cancer risk

Nina E Landvik, Shanbeh Zienolddiny, Vidar Skaug, Aage Haugen

O4 Polychlorinated biphenyls (PCB), UV radiation, and cutaneous malignant melanoma

Richard P Gallagher, Tim K Lee, Jean-Philippe Weber, Alain Leblanc, Marilyn Borugian, J Mark Elwood, Amy C MacArthur, Zenaida Abanto, John J Spinelli

P1 Abstract not submitted for publishing

P2 Association between night shift work, melatonin and estradiol in nurses

Beata Peplonska, Agnieszka Bukowska, Jolanta Gromadzinska, Wojciech Sobala, Edyta Reszka, Jenny A S Lie

P3 Mastermind-like 1 (MAML-1) as a new metastatic marker in esophageal squamous cell carcinoma

Mohammad M Forghanifard, Moein Farshchian, Reza Raeisossadati, Mohammad N Forghani, Meysam Moghbeli, Hussein Naseh, Mohammad R Abbaszadegan

P4 Polymorphisms of GSTM1, GSTT1, GSTP1 and CYP1A1 genes and susceptibility to lung cancer

Paula Mota, Michelle Horta, Luis Mesquita, Henriqueta Silva

P5 Obesity and breast cancer: inflammatory and adipocytokine correlations

Paulo C Matafome, Ana L Gomes, Manuel Gomes, Lélita C Santos, Ana B Sarmento, Raquel F Seiça

P6 Polymorphisms of estrogen receptors, ERα and GPR30: association with breast cancer susceptibility and prognosis

Susana M Alves, Luís Mesquita, Rita Sousa, Fátima Peralta, Henriqueta C Silva

P7 Breast cancer and environmental factors

J Vicente Paulo, Lélita Santos, Graça Fernandes

P8 Primary bone lymphoma

C Pissarro C Azevedo, P José A F F Tavares, M Isabel P Portela, A José L C P Santos, J Manuel P S Casanova

Session 2 - Molecular Carcinogenesis

O5 Regulation of DNA damage responses by mismatch repair

Anatoly Zhitkovich

O6 Insoluble Ni compound-induced gene amplification/gene silencing causes over-expression of microtubules/microfilaments, cell shape changes, and de-regulation of global gene expression/Ca+2 gradients, inducing morphological/ neoplastic transformation of

10T1/2 mouse embryo cells

(5)

Volume 4 Supplement 2 September 2010

BMC

Proceedings

Contents

O7 The bioenergetic signature of cancer

José M. Cuezva

O8 Roles of beta-arrestin1/2 in prostaglandin-mediated signaling and tumor development

Robert Langenbach, Huei-Chen Lao, Kyung-Soo Chun

O9 PINK1/BRPK inhibits apoptotic cell death and enahances cellular invasiveness through an activation of mTORC2 pathway

Hitoshi Murata, Masakiyo Sakaguchi, Ken Kataoka, Nam-ho Huh

O10 Receptor for activated C-kinase (RACK1) plays a central role in Ras-mediated signal transduction

Johan R Lillehaug, Line M Myklebust, Arnt Raae, Bodil Bjørndal

P9 The role of CD26 and CD40 expression in therapeutic response - experimental study in oral cancer lines

Joana P N Batista, Sílvia S Neves, A Cristina Gonçalves, Vera Alves, Ana Sarmento-Ribeiro, Marília Dourado

P10 Abstract not submitted for publishing

P11 Evaluation of the role of miR-34b in modulation of radioresistance in non-small cell lung cancer

Joana B Silva, Sílvia S Neves, A Cristina Gonçalves, Margarida Marques, Luís Mesquita, Filomena Botelho, A Bela Sarmento-Ribeiro, Henriqueta C Silva

P12 P-cadherin expression in feline mammary tissues

A Catarina Figueira, Júlio Carvalheira, M Manuela Lacerda, M Fátima Gärtner

P13 Regucalcin, a calcium-binding protein, is a new target gene in human prostate cancer?

Cláudio J Maia, Cátia V Vaz, Carina G Peres, Cecília R A Santos, Sílvia Socorro

P14 MicroRNA-21 in lung cancer: overexpression in metastasis of pulmonary adenocarcinomas and squamous cell carcinomas

Maria R Silva, Paulo Santos, Isabel Velada, Catarina Gomes, M João d’Aguiar, Lia Teixeira, João Dinis, Susana Carmona, Luisa Cortes, Lina Carvalho

P15 Involvement of mitochondrial and survival signaling in berberine-induced apoptosis in melanoma cells

Ana Burgeiro, Consuelo Gajate, El H Dakir, Paulo J Oliveira, Faustino Mollinedo

P16 Metabolic changes in human bronchial epithelial cells upon chronic exposure to hexavalent chromium

Leonardo M R Ferreira, Maria S Santos, M Carmen Alpoim, Ana M Urbano

P17 Cr(VI)-induced malignant transformation of a bronchial epithelial cell line association with altered mitochondria and bioenergetic phenotypes

Ana Sampaio, Luís Mendes, Ana C Gonçalves, Margarida Abrantes, Ana B Sarmento, Filomena Botelho, Paulo Oliveira, Vilma Sardão, Rui Carvalho, Ana M Urbano and M Carmen Alpoim

Session 3 - Tumor Microenvironment and Tumor Cell Biology

O11 Tumor Microenvironment Controls the Rate of Cancer Progression and Metastasis

Raghu Kalluri

O12 Metabolism and metastasis: in the bone marrow and beyond

Sérgio Dias

O13 The Immune Biology of Microsatellite Unstable Cancer

Magnus von Knebel-Doeberitz

O14 Targeting secreted heat shock protein-90alpha (Hsp90α) to prevent breast cancer progression

(6)

Volume 4 Supplement 2 September 2010

BMC

Proceedings

Contents

O15 JAKs and STATs in Chemoresistance

Ana Costa-Pereira

O16 Autophagy turns specific: the discovery of p62 and NBR1 as autophagy cargo receptors

Geir Bjørkøy

P18 Abstract not submitted for publishing

P19 Abstract not submitted for publishing

P20 Relation between autophagy and the resistence of glioblastoma cells to temozolomide

Anália Carmo, Helena Carvalheiro, Maria C Lopes

P21 GLUT expression and 18F-FDG uptake in breast cancer cell lines

Ana M Abrantes, Mónica Martins, Ana C Gonçalves, Maria C Rodrigues, Ana C Mamede, Sónia D Tavares, José M Lima, Adriano Rodrigues, Ana B Sarmento-Ribeiro, Maria F Botelho

P22 MDR modulation in colorectal adenocarcinoma cell lines: kinetic studies using 99mTc-sestamibi

João Casalta-Lopes, A Margarida Abrantes, Joana Rio, Mafalda Laranjo, Bárbara Oliveiros, A Cristina Gonçalves, Ana B. Sarmento-Ribeiro, M. Filomena Botelho

P23 Phenotypic analysis of breast cell lines – triple negative cells vs expressing hormonal receptors

Mafalda Laranjo, Maria J Carvalho, Artur Paiva, A Margarida Abrantes, Isabel Torgal, Carlos F Oliveira, M Filomena Botelho

P24 Abstract not submitted for publishing

P25 A nonconjugated naphthalene derivative of meso-tetra-(3-hydroxy)-phenyl-porphyrin as a sensitizer for photodynamic therapy

Abílio J F N Sobral, Ana M Urbano, Pedro Silva, Sofia M Fonseca, Cláudia T Arranja, Hugh D Burrows

P26 Polyaromatic hydrocarbons accentuate malignant phenotype of the PC3 prostate cancer cell line

Mariana O Freitas, José Oliveira, Ana M Fernandes, Maria I Coutinho, Vera Alves, Anabela Mota-Pinto, Ana B Sarmento-Ribeiro

P27 MGBG–cisplatin combination chemotherapy against breast cancer

Raquel F Gonsalves, Maria P M Marques

P28 Melanoma skin cancer: could chromone derivatives be efficient chemopreventors?

Mafalda M Dias, Maria P M Marques

P29 Exosomes from human ovarian carcinoma SKOV3 cells are enriched in glycosylated proteins

Cristina Escrevente, Peter Altevogt, Júlia Costa

P30 Delocalized lipophilic cations as a new therapeutic approach in cancer

A Barbosa Ribeiro, A Luísa Ferreira, A Cristina Gonçalves, Sílvia Neves, A Maria Araújo, Filipa Carvalho, João Carvalho, Rui M Santos, Vera Alves, Teresa Silva, José M Nascimento-Costa, Ana B Sarmento-Ribeiro

P31 Cytotoxic effect induced by combination of polyamines metabolites and endocannabinoid, anandamide, on human cancer cells: a new anticancer strategy

A Lúcia M Batista-de-Carvalho, G Tempera, N Viceconte, S Saccoccio, E Bidollari, M Nalli, Enrico Morera, Giorgio Ortar, Enzo Agostinelli

P32 An in vitro tumor-fibroblast interaction model of human oral squamous cell carcinoma

Jozséf Dudás, M Bitsche, V Schartinger, G M Sprinzl, H Riechelmann

P33 Physiologic parameters variation in ICR mice during a chemical induced liver carcinogenesis experiment

Ivo Conceição-Pereira, Nuno M Paula-Santos, Filipa O Pereira, Maria J Pires, Luis F Palomino, Aura A Colaço, Paula A Oliveira

P34 Role of VEGF signalling in the regulation of KDR expression in endothelial and tumoral microenvironment

(7)

Volume 4 Supplement 2 September 2010

BMC

Proceedings

Contents

P35 EP4-mediated prostanoid signalling promotes oral cancer progression

Karen Sapienza, Stewart Sale, Angela Hague, Ian.R. Hart, J.ohn F. Marshall, Gareth.J. Thomas

P36 Role of notch pathway and HNF1 in cell death induced by HDACs inhibitors in ovarian cancer cell lines, serous and clear cells

Fernanda Silva, Jacinta Serpa, Germana Domingues, Gabriela Silva, António Almeida, Ana Félix

P37 TRAP1 and SORCIN cooperate in a survival pathway responsible for inducing drug-resistance in human colorectal carcinoma (CRC)

Matteo Landriscina, Francesca Maddalena, Gabriella Laudiero, Maria R Amoroso, Annamaria Piscazzi, Valentina Lombardi, Alberto Fersini, Franca Esposito

P38 Dll4 blockade interferes with the bone marrow vascular niche and perturbs hematopoietic recovery following myeloablation

Leonor Remédio, Tânia Carvalho, Sérgio Dias

P39 Short-chain sphingolipids for enhanced cellular uptake of liposome-encapsulated amphiphilic anti-cancer drugs

Lília R C Pedrosa, Albert van Hell, Wim van Blitterswijk, Ann L B Seynhaeve, Alexander M M Eggermont, Timo L M ten Hagen, Marcel Verheij, Gerben A Koning

P40 Osteosarcoma contains a subpopulation of cancer stem-like cells that are highly resistant to radiotherapy

Sara R M Neves, Aurio O G Lopes, Anália do Carmo, Antero J Abrunhosa, Paulo C P S Simões, Artur A Paiva, M Filomena Botelho, Célia M F Gomes

P41 Indentification of cancer stem-like cells in osteosarcoma and their implications in response to chemotherapy

Áurio O Lopes, Sara R Neves, Anália do Carmo, Artur A Paiva, Maria Botelho, Célia M Gomes

P42 Metabolic responses of A549 lung cells to cisplatin and radiation exposure studied by 1H NMR spectroscopy Ana F Ladeirinha, Inês D Lamego, Ana M Gil, Joana B Melo, Isabel M Carreira, Iola F Duarte

P43 In vivo pulmonary metastatic profile of breast cancer cell lines expressing hormonal receptors versus triple negative

M João Carvalho, A Margarida Abrantes, Mafalda Laranjo, Francisco Falcão, Sofia Cabrita, M Filomena Botelho, Carlos F de Oliveira, Isabel Torgal

P44 New targeted therapies in myelodysplastic syndrome: the role of farnesyltransferase and proteasome inhibitors

A Cristina Gonçalves, Ana Oliveira, Diana Moreira, Silvia Neves, Vera Alves, Teresa Silva, Luís Mesquita, Henriqueta Coimbra, Marília Dourado, José M Nascimento-Costa, Ana B Sarmento-Ribeiro

P45 Targeted gene silencing for cancer treatment

Lígia C G da Silva, José S Ramalho, M Conceição P de Lima, Sérgio Simões, João N Moreira

P46 Recombinant trail: a synergistic effect in myeloid leukemias

Filipa Carvalho, A Sofia Coelho, Cátia Domingues, João A Carvalho, André Ribeiro, Rui M Santos, A Cristina Gonçalves , Vera Alves, Teresa Silva, Marília Dourado, José M Nascimento-Costa, Ana B Sarmento-Ribeiro

P47 Co-expression of E- and P-cadherin in breast cancer: role as an invasion suppressor or as an invasion promoter?

Ana S Ribeiro, Laura C Carreto, André Albergaria, Bárbara Sousa, Sara Ricardo, Fernanda Milanezi, Raquel Seruca, Manuel A Santos, Fernando Schmitt, J oanaParedes

P48 Contribution of Thomsen-Friedenreich antigens to bladder cancer malignancy: Characterization of cell line models

Paulo F Severino, Mylène A Carrascal, Helena Gouveia, M Guadalupe Cabral, Manuela Correia, Nadia Malagolini, Mariella Chiricolo, Fabio Dall’Olio, Paula AVideira

P49 Antitumoral effect of farnesiltransferase and mtor inhibitors in hepatocellular carcinoma: in vitro studies

(8)

Volume 4 Supplement 2 September 2010

BMC

Proceedings

Contents

P50 Metalloproteinase inhibitors as a potential therapeutic approach in multiple myeloma: a preliminary study

A Sofia Pais, A Cristina Gonçalves, Catarina Geraldes, José M Nascimento-Costa, Ana B Sarmento-Ribeiro

P51 Novel antitumor DNA monoalkylating agents: Synthesis and biological evaluation

Ana F Brito, M Isabel Soares, Mafalda Laranjo, A Margarida Abrantes, José A Paixão, Ana M Beja, Manuela R Silva, Teresa P Melo, M Filomena Botelho

P52 The effect of cisplatin in 5637 bladder cancer cell line

Rosário Pinto-Leite, Regina Arantes-Rodrigues, M Luís Cardoso, Lúcio Santos, Paula A Oliveira

Session 4 - Cancer Genetics and Epigenetics

O17 CDH3/P-cadherin overexpression in breast carcinomas: its regulatory mechanisms, the role in cell invasion, and the association with cancer stem cell properties

Joana Paredes

O18 Spontaneous development of lung adenocarcinoma in the CADM1 gene-deficient mice

Masayoshi Nagata, Mika Sakurai-Yageta, Daisuke Yamada, Taketo Kawai, Yumi Tsuboi, Takeshi Ito, Akihiko Ito, Midori Yoshida, Yoshinori Murakami

O19 The FRAGILOME project, a strategy for the discovery of new gene biomarkers in cancer

Manfred Schwab

O20 Gene amplification in breast cancer – looking for the molecular mechanisms

Sergei Kovalenko

O21 Molecular Genetic Study of Female Cancers in Novosibirsk, Russia

Lyudmila F Gulyaeva

O22 E-cadherin mediated cellular effects and molecular partners. Gastric cancer as an invasive model

Joana Figueiredo, Joana Simões-Correia, Joana Fernandes, Ana R Mateus, Gianpaolo Suriano, Joana Paredes, Carla Oliveira, Raquel Seruca

P53 Identification of copy number variations of chromosomes 7, 9 and 10 in human glioblastomas by SNP-arrays

Inês Crespo, Maria D Tabernero, Ana B Nieto, Olinda Rebelo, Hermínio Tão, Fernando Gomes, Catarina R Oliveira, Maria C Lopes, Alberto Orfao

P54 Circadian gene variants and MT6s level in nurses under different work shifts – preliminary results

Edyta Reszka, Beata Peplonska, Edyta Wieczorek, Jolanta Gromadzinska, Wojciech Sobala, Wojciech Wasowicz, Agnieszka Bukowska, Jenny A Lie

P55 MFSD2A is a novel lung tumour suppressor gene whose expression is modulated by a 5’-region polymorphism

Francesca Colombo, Monica Spinola, Felicia S Falvella, James P Sullivan, David S Shames, Luc Girard, Paola Spessotto, John D Minna, Tommaso A Dragani

P56 FGFR4 GLY388ARG polymorphism modulates cancer patients’ survival in pooled analysis

Elisa Frullanti, Tommaso A Dragani

P57 KRAS and EGFR mutations coexisting in lung adenocarcinoma

Vitor Sousa, Ana Alarcão, Patricia Couceiro, Maria R Silva, Maria J d’Aguiar, Lia Teixeira, Lina Carvalho

P58 Modulation of DNA damage prevention and signaling pathways in diet induced colon cancer prevention

(9)

Volume 4 Supplement 2 September 2010

BMC

Proceedings

Contents

P59 MIR-143 over-expression reduces the growth of xenograft tumors from colon carcinoma cells

Pedro M Borralho, Sofia Gomes, Raquel T Lima, Rui E Castro, Maria H Vasconcelos, Cecília M P Rodrigues

P60 Histone deacetylation - a new epigenetic target in cancer

João A Carvalho, Emília Cortesão, José D Branco, Ana C Gonçalves, Sílvia Neves, Filipa Carvalho, André Ribeiro, Vera Alves, Teresa Silva, Marília Dourado, José M Nascimento-Costa, Ana B Sarmento-Ribeiro

P61 EGFR unusual mutation status in lung adenocarcinomas

Ana Alarcão, Vitor Sousa, Patrícia Couceiro, Maria Silva, Maria J. d’Aguiar, Lia Teixeira, Lina Carvalho

P62 Identification of a common deletion region in 10q26 associated with human gliomas

Margarida Alves, Paulo Liberato, Ana Rita Conde, Manuela Mafra, Alexandra Inverno, Ana Teresa Maia, Denise Bagrel, Isabel Carreira, Miguel Brito, Carolino Monteiro

P63 STEAP1 expression in prostate cancer and its regulation by androgens

Inês Gomes, Cecília R A Santos, Sílvia Socorro, Carlos Lopes, Cláudio J Maia

P64 EGFR/erb-1, HER2/erb-2, CK7, LP34, Ki67 and p53 expression in preneoplastic lesions of bronchial epithelium

Lina Carvalho, Joana E Santo, Ana Alarcão, Patricia Couceiro, Maria R Silva, Ana Gomes, Maria J d’Aguiar, Lia Teixeira, Vitor Sousa

Session 5 - Translational Cancer Medicine

O23 Quality control in colon and rectal cancer surgery

Karl-Heinrich Link

O24 Detecting tumor responses to treatment using hyperpolarized 13C magnetic resonance spectroscopic imaging Kevin M Brindle

O25 Tumor-tailored treatment of colorectal cancer: from bench to bedside?

Marko Kornmann

O26 Targeting non-viral vectors to tumor cells and the tumor microenvironment

Vera Moura, Manuela Lacerda, Paulo Figueiredo, M Luísa Corvo, M Eugénia M Cruz, M Conceição P. de Lima, Sérgio Simões, João N Moreira

O27 Adjuvant therapy in colorectal cancer – studies of the FOGT group

Ludger Staib, Marko Kornmann, Karl-Heinrich Link

O28 “Omic” landscapes of breast cancer - the end of the beginning

Carlos Caldas

O29 Bacterial anticancer weapons: a promising tool to fight cancer

Ananda M Chakrabarty

P65 Improving the classification of brain tumors in mice with perturbation enhanced (PE)-MRSI

Rui V Simões, Sandra Ortega-Martorell, Teresa Delgado-Goñi, Yann le Fur, Marti Pumarola, Ana P Candiota, Patrick J Cozzone, Margarida Juliá-Sapè, Carles Arús

P66 NMR metabonomic study of lung cancer: metabolic profiling of tissues

Cláudia M Rocha, António S Barros, Ana M Gil, Brian J Goodfellow, Isabel M Carreira, João Bernardo, Ana Gomes, Vítor Sousa, Lina Carvalho, Iola F Duarte

P67 NMR metabonomic study of lung cancer: metabolic profiling of urine and blood plasma

(10)
(11)

!"

!" # ! $# % & # # #'

"

"

(

(

!"

!

)

)

(

(

$

$

#

#

$

$

#

#

# " $

" # $

% & ' ( '

)

) #

% % )

" % &

* (! + ## ! * + # ( # + # ' ( ! ( )' !* +%

,

&

(

&

&

#

#

(

(

#

#

(

(

,

,

" (# -! . ' (! ! " #

! ) # # *

$ $

, (

,

/

! " # !

, $ ! #

#

- ( # #

, #

" -" .

/ # 0

,

-.( ( $

" , " 0 - 12

"

(

-3 4534-1

,

/

/

0 & # %'

. ! / # ' 0 # 1 ! (

2* 2 *

# 1 ! ! (

3( ! .

/

!

* " (!

% & 2 #

* % $

! # 4-1

' #

. 3

$

1

2 3! !

" ( '$ # 3

! " '$ 4 (

' 64-! '6 ( , $ ( (

3( ( 3/ 1 ' (

1

1

! " ## !

" ( ! #

)

#6 ) 64* '

# .

(12)

&

1

4

4

&

&

(

(

'

'

4

4

##

#

#

5

5

#

#

* ! 6 ##

# ! # # !

" ! !

3( 7 , ,

' '

0

# 56 ! !

' '73

3 $ 8 '

, 8

( ! !

& ' 6 # %

" ( (( %

# 3

( (( % 39:; 3

* ",7< 3

3( !

+ ,

!

7 "

" ( " # , $

!

= ( # #

3 . .(

' #95 ( ) 95:*

' !

'

38

" # " ( 7

! ( ,

( ,

; 6 .3 3 (

+ 59: .:

7% > =% > # % % )

( 3 . 8 3( $ <1 ! 4

(

,

&

(

,

,

(

(

+

+

(

(

$

$

(

(

,

,

8

3 3 ( !

# % !

$ -'# (

/ 0 !

8 ( ( ( = ( . '

,

/

! & .

" # ! !

# % $ % $ 4 (

. $

& (

4 " #$

/

/

&3; (!< * ",7< 3

3( 7 " &/ ' >

. ( $

" !

/

!

6 ' # .

3 2 !

( ! # $ * # $ # # $ * " ! 8 ( ' , ' %

1

" # + # '

! !

( * !

" # # $ *

! " ( # $ # # $ *

" .

7 ,

1

1

* = # 3 ( 3 ( !

# % !

# (

' ?

(13)

4

>

/

/

4

4

#

#

#

#

(

(

&

&

(

(

6 #3 (! " .

$ ( % % * =!

% $ ( , $ , ? 3

@

.

6 ' 5 #

" ( # ,

* , * ,

$ 3

3 + A

4

.

& . 6

( 3 + % (

# 3

3 # 3

8 7 ! (

! B

!

? 2 &

7 #

3 # %

3 ( 3

"

" ( 3 + , $ 2

2 3

> 3(

C . ( 7/"3 "

# #

" ( ' # ,

2&( ! ,

* , *

* ,

* * ,

D/ D & ! C 3( ( !

&@ ! .

" ( ! @ #

!

! = 8

' 3 7 (

,

&

(

(14)

!

7

' #

2

4

(

(

!

(

" ( #

%

4

7!

"

(

7 %

!

7 %

1

4

3

7 %

#6

7 %

7

' #

7!

!

7 %

! A

7!

4

7 .

#

7 %

!

7

7 %

. !

7!

!

(

7 %

!

7

7!

!

7!

+

!

7 %

" ( # 8

!

7 %

7

' #

7!

! A

7!

!

(

7 %

!

7

7!

+

!

7 %

A

#

'

2

4

)

4

(

(

,

$

3

*

%

,

$ 4 (

$B (

'

2

4

)

4

(

(

,

$

3

(15)

(.

<#

%

'

B

9C

(

*

$

)

((

D

7 %

7

8

%

#

E

#

"

=

" # 6

56

#

%

%

(16)

"A 4

C 8 *4A A8 24

D 4* "A

)

?F

2

F ) G F F )F #F

D 4*A

" E

4 B H

! # $ 2 %= $

I B F G = F F

2

3

*

F

* + # J

( # J + #

G F

-$

*$8D5"A

! I

3

F

B * (

) F G B F B

$2& *6

(

# " $

G F F $

+$*& 2

#

,

"

B !

" ( (( % # 3

( (( % 39:; 3 * ",7<

3

(17)

,

! $

" ( 3 + % ( # 3

$ F$ G $ $= F

$ ,

=

$ ( % * =! %

$ ( , $ , ? 3

$= F $G $ ( F

)

!

3 * ",7< 3

F ) G $ B= F

" ( 3 + , $ 2 2 3

F G$ $ = F

A* 2

7

!

!F

B # "

G F

A4 "

7

7 B * B % !

F G F F

7

2

7 B * B % !

F G F F

!

# 7 " ( ! ' 7

F G F

8 2

=

" ( '$ # 3 ! "

'$ 4 (

(18)

,

$ %

# % $

*

KC G F FI(

!

$

L

" # ! ! # % $ % $ 4 (

$ G F = $ F FI(

2 *7

I> $>

3

7% > =% > # % % )

# > =% > J # % > )

F I $ G F

% & ' ( ' ) J

) # % % )

F G F

4

*F

" ( ! # )

I F G F F

8 " 2

$ ) $

B$

' ( ! B

$ ) $ G (F BF(

*

B$

2

' ( ! B

G (F BF(

8 *4D+ "

!F

( - 7 ! #

G F F(

!F

" ( 8 + 7 8 % #

(19)

6

1 = 7 ! #

G F F(

(

!

F

" ( 8 + 7 8 % #

( G F

#

!F

# 5 3 H !H 7 ! #

M # MN9G F

*

!F

" ( + 2 + # % E = =! " + *

G F

OI

!F

7 ! #

G F

4

F

7 8 % #

I # G F

#

! = *@" 7 % #

G F F(

!F

* ! ! F 7 #

77 G F F(

!

7F

7 ! #

G F F(

7F

( - J 7 ! J # F

(20)

F

= 8

M G F

E

3F

=

G F

4

QF

2 ' #

I G F(

#

7 ( +F

! 7 #

( # # G F

#

4 6

F

7 ! #

M # MRG F

#

!F

1 7!

# G F = F(

#

!F 4 6

! 3' ! 7 # -3 # # (

-( ! 7

IF # G ( F(

!F

7 ! #

M A G F

#

4

7F

" ( 8 + 7 8 % #

I # RG F

!

F

7 ! #

M( G F

6

2 .

F

# ( - ! 3'

(21)

(

F

7 7 E #

F F ( G F

#6

4F

" ( 8 + 7 8 % #

I GB F F(

B *

F

%

G F(

"

!

!F

! = *@" #

G F

"

H

# 56 ! !

' '73 3 $ 8 F

G ( F = F(

"

! .

F

7 ! #

G F F(

2

#

F

% Q . 1 '

G A F F(

7

F

7 ! #

G F

7

!F

" ( 8 + 7 8 % #

M M M G F

7

F

8 H B # =

G F

7

!

'F

3 7 ! #

(22)

3

F

% ( #

G F = F(

3

H

!F

( - 7 ! #

G F F(

3

5 #

F

! 7 #

# G F F(

3

#

* A

7F

! = *@" #

A F RG F

3

1

4F

" ( 8 + 7 8 % #

G F F(

4

F

7 ! #

I G F

7F

7 ! #

G F

I

!

F

( - 7 ! #

I G F

(

S

'F

( = = 7!

( 9:G F

(

4 6

F

( - 7 ! #

I ( G F F(

(

!

F

8 J # J ! 3'-7!

(23)

!

E

4F

# # 6

G F F(

!

F

# 56 ! 3 H ' ! 3' 7 !

#

( G F

!

.

7 8 % #

9KPPG F

!

4F

7 7 E #

G F F(

!

+F

" ( 8 + 7 8 % #

(# G #F F(

!

4 6

F

7 #

I G F F(

!

!F

3 H !H 7 ! #

( PG F

!

=

7 ! #

( G F F(

!

+

F

8

# G F

=

4

H

7 ! #

I G F F(

#

*F

(24)

#

. #

F

! 3' 7 ! #

# G F

*

4F

=

FI F G F

' #

7F

7 ! #

F # G F

' #

F

" ( + # % E = =! " + *

( G F(

F

7 ! #

G F

4

3 3 ( ! # % !

I( G ( (F(

4 +F

7 ! # - '=73

I ( G F

"

7F

! " ( ! #

( G F

. !F

7 ! #

( G F

F

'

F B#G F

B

%

(25)

*

H

+F

! ' 73 2 2

F G F

*

F

% !

G ( (F(

*

H

F

7 ! #

F F G F

*

E

!F

2 ' #

F G F(

*

+.

F

7 ! #

# G F(

(

"F

" ( 8 + 7 8 % #

( G F

%F

7 ! #

G F F(

3F

( #

G F

*F

- !2 # # 7

G F(

*

F

7 ! #

F G F

=*

F

! 3' 7 ! #

(26)

(

4

3 ( H = != 8 ' 7 3 2 2

I F ( G F

* A

3 3 ( ! # % !

G ( (F(

#

7F

" ( 7 8 !H # #

( F # G F F(

#

"

F

! 3' 7 ! #

M9NG F

#

7

7 8 !H # #

F # F G F

#

A

F

3 " ( 7 ! #

# G F F(

#

4

F

7 ! #

I F # G F

#

.

F

F G F

#

!

*F

1 7 ! # 7!

# G F F(

.

4F

" ( 7 % #

(27)

. #

!F

# # 6

G F F(

+.

!F

7 ! #

# RRG F(

!F

" ( 8 + 7 8 % #

G F F(

*$8D5"A

C 6 *$

,

4 =

" ( ( , = # * ( ,

TNG F

L

L

=

" ( ( , = # * ( ,

I C:9G # F

*D

A

3

#

!F

! ! ( *

! " # # $ * J ! " ( # $ #

# $ *

# G F

, #

$

3 2 ! ( !

# $ * J # $ # # $ *

$ # G F

8 A2

B#

4

H !F

. ! # ' 2* 2 *

# 1 ! ! (

I B# G F F

D2A4$

6A2+

&

, #

!F

" ( # ,J * , *

,

(28)

" ( ' # ,J 2&( !

,J * , * J

* J * * ,

NTUG F F $

=

" # " ( 7 ! ( ,J

( ,

F =( G ( F F $

(

B

,

" ( % % ! "

Q ! # ,

$F ( B GA F F $

4 $ 2$4 $*" 2

.

*F

2 ! * %

F ( G F

D2A4$

4 4$

C

&$*A

$

!F

" ( ! @ # !

( G F

F

!"

G G F #

2

B

# "

#

G( F

4 $

2 B

! 3 ( 7

I $ G F

,

*

# ! " ! !

$ G F # F

(

4

(

* " ( ! !

-, $ ! #

(29)

*

% & 2 #

* % $

9G F F #

?

" ( " = ( # #

, $ !

) G F

7

(

% !F"F

9G F

V

*

+F

! =, ) L $

G $ F

<

$ #

" ( ! " # !

) # # *

Referências

Documentos relacionados

O EP conferido à APC, tais como: aquecimento, treino de flexibilidade e CI, não são tão fortes como as conferidas por CEM. Entretanto ao se pensar em maneiras práticas, as APC

Franco Oliveira Cocuzza (aposentado), com prejuízo de sua Vara, cessando a designação anterior. Designado para auxiliar a 8ª Câmara de Direito Privado a partir de 16/05/13, assumindo

A Figura 6 mostra a evolução das extensões nos estribos instrumentados para os vários patamares de drift. O surgimento desta fenda foi controlado de forma mais

Bežični kontroler sobne temperature (opcija) Pumpa Radijator Struja Drugi izvori energije (gas,nafta) Hidrobox Bojler Uključivanje ON/OFF bojlera po potrebi Mešni rezervoar

Narudžbena oznaka Sadržaj paketa Pakirano po Broj artikla Rotacijski laser PRI 2 Komplet sadrži rotacijski laser PRI 2, 2 alkalne. baterije tipa D, daljinski upravljač PRA 2, 2 alkalne

O uso deste produto nao esta sujeito ao controle direto, para tanto, os usuários devem sobre sua própria responsabilidade seguir com as leis e regulamentos para o correto manuseio

● Orientar o paciente para, ao menor sinal de infecção no local (hiperemia, dor, edema, adenomegalia), procurar a unidade de saúde mais próxima de sua casa.. ● Encaminhar

129 Extensão subjetiva da eficácia do caso julgado formado sobre a existência dum caminho público em ação entre o município e o proprietário do prédio por ele atravessado ....